Oruka Therapeutics CEO Lawrence Otto Klein Reports Sale of $2.39 Million in Common Shares

Bitget2026/11/02 22:47

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Oruka Therapeutics CEO and director Lawrence Otto Klein sold 25,000 common shares on Nov. 2, 2026.
Weighted-average sale prices ranged from $94.7718 to $98.4033 per share.
Klein also exercised employee warrants to acquire 25,000 common shares at $7.80 each.
Following the transactions, he directly owned 923,128 common shares and 1,503,513 employee warrants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000907654-26-000112), on November 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Oruka Therapeutics CEO Lawrence Otto Klein Reports Sale of $2.39 Million in Common Shares

You may also like

Crypto prices